Advertisement

Research Article Free access | 10.1172/JCI104709

CHLORPROPAMIDE-INDUCED LEUCINE HYPOGLYCEMIA

C. Lucas and G. Reaven

Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif.

†

Recipient of training grant 2A-5021-(C5), U. S. Public Health Service.

‡

Address requests for reprints to: Dr. G. Reaven, Department of Medicine, Stanford University, Palo Alto, Calif.

*

Work supported in part by grant A-4293 from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md.

Find articles by Lucas, C. in: JCI | PubMed | Google Scholar

Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif.

†

Recipient of training grant 2A-5021-(C5), U. S. Public Health Service.

‡

Address requests for reprints to: Dr. G. Reaven, Department of Medicine, Stanford University, Palo Alto, Calif.

*

Work supported in part by grant A-4293 from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md.

Find articles by Reaven, G. in: JCI | PubMed | Google Scholar

Published February 1, 1963 - More info

Published in Volume 42, Issue 2 on February 1, 1963
J Clin Invest. 1963;42(2):230–238. https://doi.org/10.1172/JCI104709.
© 1963 The American Society for Clinical Investigation
Published February 1, 1963 - Version history
View PDF
Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1963): No description
Advertisement
Advertisement